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Abstract
Background: Gastrointestinal complaints are common among long distance runners. We hypothesised that small
intestinal bacterial overgrowth (SIBO) is present in long distance runners frequently afflicted with gastrointestinal
complaints.
Findings: Seven long distance runners (5 female, mean age 29.1 years) with gastrointestinal complaints during and
immediately after exercise without known gastrointestinal diseases performed Glucose hydrogen breath tests for
detection of SIBO one week after a lactose hydrogen breath test checking for lactose intolerance. The most
frequent symptoms were diarrhea (5/7, 71%) and flatulence (6/7, 86%). The study was conducted at a laboratory.
In none of the subjects a pathological hydrogen production was observed after the intake of glucose. Only in one
athlete a pathological hydrogen production was measured after the intake of lactose suggesting lactose
intolerance.
Conclusions: Gastrointestinal disorders in the examined long distance runners were not associated with small
intestinal bacterial overgrowth.
Introduction
Gastrointestinal (GI) disturbances during or immediately
after exercise are common among runners [1,2]. 20-50%
of long distance runners are affected [3]. Both the upper
and lower GI tract are involved. Symptoms are vomiting,
nausea, bloating, heartburn and flatulence as well as
watery and bloody diarrhea and anal incontinence [4].
The causative mechanisms are not completely under-
stood. The mechanical irritation of the GI tract during
running can change intestinal motility [5], additionally
exercise causes a reduction of the mesenteric blood flow
[6] and both may contribute to the symptoms. Both, a
GI dysmotility as well as a reduced mesenteric blood
flow are well known risk factors for development of
small intestinal bacterial overgrowth (SIBO) [7,8]. Clini-
cal manifestations of SIBO involve the upper and lower
GI tract and are similar to the complaints of long dis-
tance runners. The gold standard in diagnosing SIBO
consists in culture of jejunum aspirate for bacterial
counts, but also non-invasive hydrogen breath testing
with glucose (GHBT) is well established [9-12]. We
hypothesized that due to the high weekly training
volume with irritation of GI motility and repeated
impairment of the mesenteric perfusion SIBO is present
in long distance runners with frequent GI symptoms.
Methods
Seven long distance runners (5 female, 2 male) were
recruited with the help of the headcoach for long dis-
tance runners of Baden-Württemberg. Baseline charac-
teristics are given in table 1.
We only included otherwise healthy, non-smoking
long distance runners with a training experience of ≥ 5
years and a minimum two years lasting, unexplained
history of frequent GI complaints (nausea, eructation,
heartburn, angina pectoris, vomiting, abdominal cramp-
ing, flatulence, diarrhea, or stitch) during or within one
hour after running. “Frequent” was defined as at least
every other run, and they must have had at least two of
the above-mentioned symptoms. By a modified self-
assessment questionnaire used in a previous study [13],
the following exclusion criteria were assessed: known GI
diseases, family history of bowel disease, indication that
* Correspondence: kai.schommer@med.uni-heidelberg.de
1Department of Internal Medicine, The University Hospital Heidelberg,
Division of Sports Medicine, Im Neuenheimer Feld 410, 69120 Heidelberg,
Germany
Full list of author information is available at the end of the article
Schommer et al. Journal of Negative Results in BioMedicine 2011, 10:8
http://www.jnrbm.com/content/10/1/8
© 2011 Schommer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.intake of special food or beverage could explain the GI
complaints, intake of antibiotics or proton-pump inhibi-
tors within one month before the study started. Table 2
summarises the GI symptoms reported in the question-
naire. Clinical examination of the abdomen including
auscultation and palpation were normal. ECG at rest
and during exercise and blood examinations for haemo-
gram, ESR, Aspartate- and Alanine-transaminase, g-glu-
tamyltransferase, creatinine, urea and ferritine were
normal. Body fat composition was determined by 3-
point skin fold calipometry [14]. After preexamination, a
lactose hydrogen breath test (LHBT) and at least one
week later a GHBT on “Wasserstoff-Atemtest” (IFM
GmbH, Wettenberg, Germany) were performed after a
12 hour fasting period. These tests were performed in a
laboratory of the division of gastroenterology where this
examination is routine practice. After two measurements
of baseline values for exhaled hydrogen, either 50 g lac-
tose or 75 g glucose (both dissolved in 200 ml of water)
was applied and breath samples were analysed for
hydrogen every 10 minutes for 3 hours. SIBO is sus-
pected if a clearly recognisable hydrogen peak is present
and exhaled hydrogen exceeds 20 parts per million over
baseline values in both tests [15,16]. Late hydrogen
peaks in the GHBT can be caused by a faster GI transit
time for glucose and thus simulate SIBO [9]. Therefore,
LHBT was performed as a control in the case of a posi-
tive GHBT: SIBO must also result in a positive LHBT
[17], but a faster transit time for Glucose does not.
Written informed consent was obtained from the sub-
jects, and the study has been approved by the Ethics
Commitee of the Medical Faculty of the University of
Heidelberg.
Results
In none of the seven athletes a pathological hydrogen
production after application of glucose was observed
(Figure 1). In subject 3, a pathological hydrogen produc-
tion was measured after intake of lactose but not after
glucose, suggesting lactose intolerance. Incidentally, this
athlete never had any problem after the intake of milk
products. In the remaining 6 subjects, LHBT was unre-
markable (Figure 2). Subject 4 reported bloody diarrhea
after a marathon race two years before. At this time,
gastroscopy only revealed some gastric erosions without
helicobacter pylori infection whereas colonoscopy was
unremarkable.
Discussion
This study does not provide evidence of SIBO as a com-
mon cause accounting for GI problems in long distance
runners. All of the investigated runners were frequently
afflicted with the usually reported GI symptoms in run-
ners, but none of them showed a pathological GHBT. In
the absence of an early peak in this test which could
indicate SIBO, the late peak in subjects 1 and 2 in the
GHBT is attributable to the passage of the glucose into
the colon. This conclusion is supported by the unre-
markable LHBT in both runners. The sensitivity and
specificity of the GHBT in detecting SIBO was reported
to be 62% and 83% [18,19]. With a given prevalence of
SIBO in younger adults aged 24 to 59 years of 5-10%
[20], the negative predictive value of an unremarkable
GHBT is 95-98%. Considering the consistent negative
findings in our study we conclude that SIBO is not a
common cause for the GI problems of the long distance
Table 1 baseline characteristics
subject sex age
[years]
body
mass index
[kg/m
2]
body
fat
[%]
training
experience
[years]
weekly training
mileage
[kilometers]
training
sessions
[/week]
running speed at
4 mmol/l lactate threshold
[km/h]
1 female 25 19.5 14.1 6 120 10 16.6
2 male 33 20.6 8.5 9 120 10-12 18.3
3 male 27 22.1 13.3 8 60 11 16.8
4 female 21 20.8 14.1 6 60 4-6 13.9
5 female 33 19.8 15.8 7 100 7 15.6
6 female 38 21.8 15.3 17 60 6 13.2
7 female 27 22.1 20.7 7 60 6 13.7
Table 2 distribution of gastrointestinal symptoms
symptoms total during running after running
n% n % n %
nausea 00 0 0 0 0
eructation 2 29 1 14 1 14
heartburn 2 29 1 14 1 14
angina pectoris 00 0 0 0 0
vomiting 11 4 0 0 1 1 4
abdominal cramping 3 43 3 43 3 43
flatulence 6 86 3 43 3 43
diarrhea 5 71 3 43 5 71
stitch 11 4 0 0 1 1 4
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Page 2 of 4runner. It appears that the daily duration of the reduced
mesenteric blood flow and of the mechanical GI tract
concussion does not last long enough in these runners
t oc a u s eS I B O .T h ep o s i t i v eL H B Ti ns u b j e c t3e i t h e r
could be false-positive or indicates a real lactose intoler-
ance. It is reported that lactose maldigesters can usually
tolerate small amounts of lactose without symptoms
[21]. This could explain why this athlete is asympto-
matic except when running. The self-assessment ques-
tionnaire did not reveal the intake of lactose-containing
food or dietary supplements in connection with running
and thus, lactose intolerance is not the reason for the
GI symptoms in this athlete.
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Figure 2 results of the lactose hydrogen breath test.
Figure 1 results of the glucose hydrogen breath test.
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